Search

everythinglearnresearchcommunity

for

Search:↓

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Hidradenitis suppurativa treatment should be tailored to the individual, with quitting smoking being important.

Finasteride reduces Hidradenitis Suppurativa flare-ups in children and teens, but long-term safety is unknown.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

Tattooing helps treat skin conditions, reconstruct nipple-areola, mark radiation fields, and locate lesions.

Research on epidermal stem cells has advanced significantly, showing promise for improved clinical therapies.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

Ginsenoside F2 from ginseng may increase hair growth better than standard treatments by affecting cell growth signals.

Basal cell carcinomas have much higher levels of Vitamin D3 receptors compared to healthy skin.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Iron deficiency may contribute to hair loss.

Hair microRNAs could be effective biomarkers for diagnosing scleroderma.

CD98hc's role in skin health decreases with age.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Eating isoflavone can help mice grow hair by increasing a growth factor.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.